Literature DB >> 21502103

British Thoracic Society adult community acquired pneumonia audit 2009/10.

Wei Shen Lim1, Mark Woodhead.   

Abstract

BACKGROUND: The updated British Thoracic Society (BTS) Guidelines for the management of community acquired pneumonia (CAP) in adults was published in October 2009. In conjunction with the Guidelines, the first national BTS audit of adult CAP was conducted.
METHODS: An audit tool was developed as part of the Guidelines. Members of the BTS were invited to participate in the audit capturing data relating to acutely ill adults admitted to hospitals in the U.K. and treated for CAP within the period 1 December 2009 and 31 January 2010. Data entry using the web-based audit tool closed in May 2010.
RESULTS: Of 2749 submissions from 64 institutions; 8 were excluded due to inconsistent data. The mean age of patients was 71 years (range 16-105 years). The CURB65 score was 0 to 1 in 40% of patients, 2 in 30% and 3 to 5 in 30%. Five hundred and three (18.3%) patients died in hospital within 30 days, 101 (20.1%) within 1 day of admission. Initial empirical antibiotics were in accordance with local CAP guidelines in 1478 (55.5%) patients and were administered intravenously in 712 (65%), 603 (74%) and 743 (90%) patients with CURB65 scores 0 to 1, 2 and 3 to 5 respectively. Within 4 hours of admission, a chest x-ray was obtained in 83% of patients and the first dose of antibiotics was administered in 58%.
CONCLUSIONS: The burden of CAP is high. Efforts should be directed at improving adherence to local CAP guidelines and specific processes of care.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21502103     DOI: 10.1136/thoraxjnl-2011-200081

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  14 in total

Review 1.  Community acquired pneumonia: assessment and treatment.

Authors:  Caroline M Patterson; Michael R Loebinger
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

2.  Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia.

Authors:  P P España; A Capelastegui; A Bilbao; R Diez; F Izquierdo; M J Lopez de Goicoetxea; J Gamazo; F Medel; J Salgado; I Gorostiaga; J M Quintana
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-05       Impact factor: 3.267

3.  Management of severe community-acquired pneumonia in Brazil: a secondary analysis of an international survey.

Authors:  Lígia Rabello; Catarina Conceição; Katia Ebecken; Thiago Lisboa; Fernando Augusto Bozza; Márcio Soares; Pedro Póvoa; Jorge Ibrain Figueira Salluh
Journal:  Rev Bras Ter Intensiva       Date:  2015-03-01

4.  Procalcitonin for selecting the antibiotic regimen in outpatients with low-risk community-acquired pneumonia using a rapid point-of-care testing: A single-arm clinical trial.

Authors:  Mar Masiá; Sergio Padilla; Victoria Ortiz de la Tabla; Matilde González; Cristina Bas; Félix Gutiérrez
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

5.  Empiric Antibiotic Therapy in the Treatment of Community-acquired Pneumonia in a General Hospital in Saudi Arabia.

Authors:  Jaffar A Al-Tawfiq; Hisham Momattin; Kareem Hinedi
Journal:  J Glob Infect Dis       Date:  2019 Apr-Jun

6.  Feasibility study for early supported discharge in adults with respiratory infection in the UK.

Authors:  Andrea M Collins; Odiri J Eneje; Carole A Hancock; Daniel G Wootton; Stephen B Gordon
Journal:  BMC Pulm Med       Date:  2014-02-26       Impact factor: 3.317

7.  Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI).

Authors:  Ilija Kuzman; Alexandr Bezlepko; Irena Kondova Topuzovska; László Rókusz; Liudmyla Iudina; Hans-Peter Marschall; Thomas Petri
Journal:  BMC Pulm Med       Date:  2014-06-30       Impact factor: 3.317

8.  Adherence to therapeutic guidelines for patients with community-acquired pneumonia in Australian hospitals.

Authors:  Nr Adler; Hm Weber; I Gunadasa; Aj Hughes; Nd Friedman
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2014-09-14

9.  Clinicians' attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza.

Authors:  Naomi Bradbury; Jonathan Nguyen-Van-Tam; Wei Shen Lim
Journal:  BMC Health Serv Res       Date:  2018-05-02       Impact factor: 2.655

10.  An audit of community-acquired pneumonia antimicrobial compliance using an intervention bundle in an Irish hospital.

Authors:  Brendan O'Kelly; Ana Rueda-Benito; Mary O'Regan; Katherine Finan
Journal:  J Glob Antimicrob Resist       Date:  2020-08-12       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.